🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Need to brush up on your toxicology? Need to teach others toxicology remotely? Why not flip the classroom? Check out these 3 modules that are available free from MMTI and AACT at clintox.org/clinical-toxic…

Two EM PharmD positions at MUSC in Charleston, SC!! Looking for some great people to join a fabulous team! Melanie Smith Condeni Carolyn Magee Bell @EMPharmD2B careers.pageuppeople.com/mob/756/cw/en-…

What is the role of sugammadex in the emergency department? jem-journal.com/article/S0736-… New narrative from our group here at UVM Medical Center University of Vermont Emergency Medicine. 📰katelin morrissette Skyler Lentz Blake Porter Brit Long Alex Koyfman JEM_Journal AAEM

Are you using Sugammadex in your Emergency Department? Here are our thoughts on its use in the ED. katelin morrissette Kyle DeWitt Blake Porter Alex Koyfman Brit Long #FOAMed sciencedirect.com/science/articl…

We’re so excited to announce the Emergency Medicine PHARMacotherapy research NETwork (EMPHARM-NET)! Our goal is to foster and conduct high quality, transformative, multidisciplinary research pertaining to pharmacotherapy in EM patients across the US 🚨🚑💊 #TwitteRx

fda.gov/safety/medical…

Thanks ⁦The Daily Iowan⁩ for taking an interest in our research network! Time to get to work 🙌💪 Brett Faine Megan Rech, PharmD, MS ⁦@CBthePHARMD⁩ ⁦Blake Porter⁩ ⁦David Zimmerman⁩ ⁦⁦Giles⁩ ⁦@GilbertPharmD⁩ ⁦⁦ dailyiowan.com/2021/04/05/uni…

🚨Check our first group publication! 🚨 Staying InformED: Top emergency medicine pharmacotherapy articles of 2020 sciencedirect.com/science/articl… Highlights: 🔷TXA 🔷Ketamine vs. etomidate 🔷Stroke 🔷All things EM ID! #TwitteRx David Zimmerman Megan Rech, PharmD, MS Brett Faine

🚨Interested in a PGY2 Emergency Medicine Residency?🚨 Learn more about our program here at UVM Medical Center during a free virtual open house!💊 Register using the link or QR code below: surveymonkey.com/r/J87WBXQ

🚨PGY2 EM Pharmacy Residency Open House🚨 💰FREE and virtual 📈Fill out the quick survey via link or QR code below to register! 📩Zoom Meeting info will be emailed after registration surveymonkey.com/r/J87WBXQ

Interested in joining a fun EM pharmacy team that loves all things academia? Check out our new job posting at the University of Iowa. DM with any questions. uiowa.referrals.selectminds.com/jobs/clinical-…

Thrilled to have Abby Bailey kick off day 2 of the #EMPRx22 conference! So many more great sessions coming your way today. *see empowerx-conference.com for session changes at 1:30, 4:30, and 5:30 pm EST

🚨📢First study from EMPHARM-NET hot off the press! High Prevalence of FQ-Resistant UTI Among US ED Patients pubmed.ncbi.nlm.nih.gov/35652493/ Brett Faine Alan Gross @CBthePHARMD Giles David Zimmerman Gavin Howington Blake Porter Alicia Mattson Abby Bailey #TwitteRx

Welcome back... #StoweEM23 📢Engaging talks by @EvieMarcolini Skyler Lentz Sergey Motov @VTEMSONO Lindsay Reardon Katie David Mackenzie and many more! 💻Register here: med.uvm.edu/cmie/2023_emer…

Although all BZDs are considered 1st line tx in status epilepticus, Lorazepam hangs out in 🧠 tissue the longest. #ASHP22 Salia Farrokh, PharmD, BCCCP, FNCS @ASHP_EMPharm

Work hard, play hard! 🍻⁦EMPHARM-NET⁩ crew out at #ASHP22. Exciting research coming your way soon, but first cocktails🍹 🚨#EMRx #TwitteRx ⁦Brett Faine⁩ ⁦Megan Rech, PharmD, MS⁩ ⁦@CBthePHARMD⁩ Alicia Mattson Blake Porter Zlatan Coralic ⁦Lance Ray⁩ ⁦ASHP⁩

🚑🚨VERY exciting news for EM PharmDs: We are forming the Academic EM Pharmacist Interest Group within SAEM See the link for how to join, leadership, networking, resident opportunities, & more! We need your help to make it a success! 🙌 #TwitteRx saem.org/about-saem/aca…

🔥Hot off the press: EMPHARM-NET study of 233 ED patients w/ pyelonephritis: 💉40% received IV antibiotics 💊 most common PO ABx: cephalexin, ciprofloxacin, cefdinir, & TMP-SMX 🦠Inactive therapy rate 10.3% & IV ABx ⬇️ odds of inactive therapy pubmed.ncbi.nlm.nih.gov/38482607/